CORMORANT ASSET MANAGEMENT, LP – Y-mAbs Therapeutics, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$2.16M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
-4.69%
quarter
Y-mAbs Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -107K | $14.42 | 150K | |
| Q2 2022 | share | 0.00% | 0 shares | 488K | $15.13 | 150K | |
| Q1 2022 | share | Decrease | -50.00% | -150K shares | -3.08M | $11.88 | 150K |
| Q4 2021 | share | Decrease | -40.00% | -200K shares | -9.40M | $16.93 | 300K |
| Q3 2021 | share | Decrease | -37.50% | -300K shares | -12.77M | $28.54 | 500K |
| Q2 2021 | share | Decrease | -34.96% | -430K shares | -10.15M | $33.8 | 800K |
| Q1 2021 | share | Decrease | -25.98% | -431.64K shares | -45.07M | $30.24 | 1.23M |
| Q4 2020 | share | Increase | +18.88% | 263.94K shares | 28.61M | $49.51 | 1.66M |
| Q3 2020 | share | Decrease | -11.24% | -176.98K shares | -14.36M | $38.39 | 1.39M |
| Q2 2020 | share | Decrease | -9.09% | -157.51K shares | 22.81M | $43.2 | 1.57M |
| Q1 2020 | share | Increase | +8.10% | 129.82K shares | -4.86M | $26.1 | 1.73M |
| Q4 2019 | share | Increase | +81.31% | 718.57K shares | 27.04M | $31.25 | 1.60M |
| Q3 2019 | share | Decrease | -11.62% | -116.2K shares | 162K | $26.06 | 883.8K |
| Q2 2019 | share | Increase | +39.77% | 284.51K shares | 4.11M | $22.87 | 1M |
| Q1 2019 | share | Increase | +267.35% | 520.71K shares | 14.79M | $26.21 | 715.48K |
| Q4 2018 | share | Decrease | -2.62% | -5.23K shares | -1.35M | $20.34 | 194.76K |
| Q3 2018 | share | Increase | 0.00% | 200K shares | 5.31M | $26.56 | 200K |